Prostate cancer | Clinique La Rive

Predisposition

While genetic predisposition is significant, certain lifestyle factors also contribute to the risk of prostate cancer.

Linked to aggressive forms of prostate cancer due to chronic inflammation and metabolic changes.

Reduces overall metabolic and hormonal balance

Associated with poorer outcomes and higher rates of recurrence after treatment.

Diets high in processed meats and saturated fats are associated with increased risk.

Early stage prostate cancer is often asymptomatic, but symptoms may develop as the disease progresses.

Difficulty starting or stopping urination, low flow, or frequent urination, especially at night.

A sign of advanced illness.

Indicates a possible spread to nearby tissue.

Suggests bone metastases, which are common in advanced stages.

Early and accurate detection improves care and reduces unnecessary interventions.

Measures the number of atherogenic lipoproteins.

High risk
Rapid increases or values >10 ng/mL that may indicate how fast the cancer is progressing.

Normal
PSA <4 ng/mL

Offers detailed imaging to distinguish benign from malignant conditions.

Evaluate proteins to predict cancer aggressiveness.

Prostate cancer treatment is highly personalized, balancing effectiveness and quality of life.

For low-risk cases, involves regular follow-up instead of immediate treatment.

Removal of the prostate gland for localized cancer.

External beam or brachytherapy for localized or advanced cases.

Lowers testosterone to slow cancer growth.

Used for advanced or hormone resistant cancers.

Immune treatments like checkpoint inhibitors and adoptive cell therapy (ACT).